JAK-IN-10

CAS No. 916741-98-5

JAK-IN-10( —— )

Catalog No. M33204 CAS No. 916741-98-5

JAK-IN-10 is a JAK inhibitor that can be used for the research of dry eye disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 120 Get Quote
5MG 177 Get Quote
10MG 260 Get Quote
25MG 415 Get Quote
50MG 585 Get Quote
100MG 772 Get Quote
500MG 1539 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JAK-IN-10
  • Note
    Research use only, not for human use.
  • Brief Description
    JAK-IN-10 is a JAK inhibitor that can be used for the research of dry eye disorders.
  • Description
    JAK-IN-10 is a JAK inhibitor. JAK-IN-10 can be used for the research of dry eye disorders. JAK-IN-10 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • In Vitro
    JAK kinases are a family of cytoplasmic protein tyrosine kinases including JAK1, JAK2, JAK3 and TYK2. Each of the JAK kinases is selective for the receptors of certain cytokines, though multiple JAK kinases may be affected by particular cytokine or signaling pathways.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    916741-98-5
  • Formula Weight
    427.45
  • Molecular Formula
    C20H18FN5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C=1N=C(NC2=CC=C(OCC#C)C=C2)C(F)=CN1)C3=CC(S(N)(=O)=O)=C(C)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hong Ren,et al. Composition for ophthalmic administration.US20140206708A1.
molnova catalog
related products
  • Tyk2-IN-30

    TYK2-IN-30 is a potent, selective and orally active Tyk2 inhibitor with Ki of 0.7 nM.

  • JAK-IN-10

    JAK-IN-10 is a JAK inhibitor that can be used for the research of dry eye disorders.

  • PRN371

    PRN371 is a novel potent, selective JAK3 inhibitor with IC50 of 0.5 nM.